Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Results of Admiral Markets AS bond buyback offer
-
Italy–Canada Business Forum in Toronto: Strengthening Bilateral Relations With the Support of the OpportunItaly Platform
-
LHV Group's own share acquisition transactions
-
HKTB Partners with World’s Leading Wine and Spirits Event Organiser Secures Exclusive Hosting of Premier International Event Vinexpo Asia in Hong Kong for Five Consecutive Years
-
HKTB Partners with World’s Leading Wine and Spirits Event Organiser Secures Exclusive Hosting of Premier International Event Vinexpo Asia in Hong Kong for Five Consecutive Years
-
Remittances Reach Well Beyond Major Cities as Older Users Send Money More Frequently
-
Notification about disposal of voting rights
-
Notification on transactions in the Issuer's securities
-
Form 8.3 -DCC plc
-
INVL Technology announces its net asset value as of 30 September 2026 and corrects its net asset value as of 30 June 2026
-
INVL Technology Interim information for 9 months of 2026
-
Cleanfarms reports record-setting collections for Canadian agricultural plastics recovery
-
Direct Energy Regulated Services Announces Natural Gas Rates for November 2026
-
National Advertising Division Finds Carpe’s Reference Price Supported; Recommends Carpe Modify or Discontinue Savings and Comparative Claims
-
Following National Advertising Division Challenge, Davids Modifies and Discontinues Certain Claims for its Pulling Oil Oral Rinse
-
HII Appoints Renee Swan as Executive Vice President and Chief Human Resources Officer
-
ACS and CX2 Partner to Advance Integrated Counter-Drone Defense Capabilities
-
Harvia Plc: Managers' transactions - Lengauer
-
AS Silvano Fashion Group Consolidated Interim Financial Report for Q3 and 09m of 2026
-
Halloween Peptide Sale 2026: Kylo Peptides Announces $1 Research Vial Sale With Orders of $200 or More
-
Sodexo - Availability of the Fiscal 2026 Universal Registration Document
-
BetMGM Marks 100 Days in Alberta
-
Boehringer Ingelheim registers Phase III trial investigating verducatib in COPD
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq
-
The 16th China Photography Festival opens in Sanmenxia
-
Halloween THC Sale: Exhale Wellness Takes $100 Off Every $250 Order Sitewide With Code TREAT100
-
Anthropic Files S-1 as GraniteShares' AIL and ANS ETFs Await Launch
-
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
-
Anthropic Files S-1 as GraniteShares' AIL and ANS ETFs Await Launch
-
Notice of Settlement Agreement
-
KVH Industries to Host Third Quarter Conference Call on November 5, 2026
-
Israel David LLC Secures Significant Litigation Victory for Hedge Fund Manager Against Novartis
-
Why Kraig Labs’ Spider Silk Could Have a Future in Aerospace
-
Vivakor Announces Proposed Hydrogen Plant and Fueling Station at a Texas International Airport
-
NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage
-
Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin
-
Second Intangible Cultural Heritage and Healthy Living Conference Held in Dong'e, Shandong
-
Second Intangible Cultural Heritage and Healthy Living Conference Held in Dong'e, Shandong
-
Trust Stamp Appointed Exclusive Technology Partner for AFCAS, Ghana’s National Fire Safety Digitisation Programme
-
NRC Completes Landmark Safety Review of X-energy’s Xe-100 SMR
-
Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit
-
Syndax’s Revuforj® (revumenib) Wins Prestigious 2026 Prix Galien USA Award for Best Product for Rare/Orphan Diseases
-
Ledyard Financial Group Earns a Record $2.5 Million, or $0.73 Per Diluted Share, in Q3 2026 and Declares Quarterly Cash Dividend of $0.21 Per Share
-
Luda Technology Group Announces Execution of Acquisition of 55% Stake in Asia AI Data Centre & Quantum Technology and Signing MOU with Huazhi Future to Explore Strategic Opportunities in AI Infras
-
Atsena Therapeutics Reports New Preclinical Data Demonstrating Robust MYO7A Expression and Favorable Safety for ATSN-301, a Laterally Spreading Dual AAV Vector-based Gene Therapy for Usher Syndrome Ty
-
EVgo to Report Third Quarter 2026 Results on November 9
-
VyOS Networks Opens Waitlist for Pre-Validated VyOS + Supermicro Routing System
-
Luda Technology Group Announces Execution of Acquisition of 55% Stake in Asia AI Data Centre & Quantum Technology and Signing MOU with Huazhi Future to Explore Strategic Opportunities in AI Infrastruc
-
ProLogium Announces Appointment of Airbus Senior Vice President Greg Ombach as Independent Director
-
BioNexus Launches New Corporate Website with Expanded Business and Investor Resources
